Live · 24 Oct 2026 SPX 7,623.68 -0.52% NDX 28,957.53 +0.00% VIX 19.45 +2.21% GOLD 4,007.90 -1.29% CL 103.27 +3.82% BTC 80,381.70 -0.85%
NAS100 28,958 S&P 7,624 −0.52% GOLD $4,008 −1.29% BTC $80,382 −0.85% VIX 19.45 +2.21% live tape · as of 19:02 UTC
The Screen · Basic Materials · Gold

NovaGold Resources Inc. logoNovaGold Resources Inc.

NG · NYSE American · USD · Market cap $2.8B · 12 employees

NovaGold Resources Inc.

FAIL · Does not pass the screen
6.47 USD

Price as of 20 Oct 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-10-20 · the tape above runs as of 19:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price6.47 USD at the 20 Oct 2026 close
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.39)
  • Last reviewed20 Oct 2026 (4 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
8.738.7310.35

What this means: price 6.47 against the desk's fair-value range, base estimate 8.73, over the last year.

Current read
Markdown ?
Screened · screened 2026-10-20
  • Trend Markdown
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.39, read 2026-10-21
  • Ethical does not pass the values gate
Price6.47 USD
Fair value8.73
Ethical score70.0/100
Our investment reviews on this name
2026-09-24Read Markdown7.36-12.1% to today ✓Markup gives way to Markdown after a 21% slide in 3 weeks
2026-09-06Read Markup9.32-30.6% to today Distribution gives way to Markup after an 80% rise in 4 weeks
2026-08-06Read Distribution5.18+24.9% to today Markup gives way to Distribution after a 30% slide in 5 weeks
2026-07-02Read Markup7.44-13.0% to today First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markdown label.

NovaGold Resources Inc. holds its Markdown at $6.47. The statistical read favours the sellers, held for 2 days.

As held on the ledger · 2026-10-20
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 2 days
Price at the screen$6.47
ValuationN/A trailing · -32.29 forward price to earnings
Values screenFAIL · score 70.0
Beta2.35
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 49.73% Below 33% Interest-bearing debt is 49.7% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 1.31% Below 33% Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit. Pass
Receivables 32.81% Below 49% Money owed to the company is 32.8% of assets, under the 49% limit. Pass
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

NovaGold Resources's business is in a permissible area, but its interest-bearing debt is about 50% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-10-24. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when NG's ethical verdict changes

Today NG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

8.73Conservative8.73Base case10.35Growth case 6.47Price

Fair value range in USD, drawn from the 2026-10-20 screen. The gold marker is the market price at the same screen. A 35.0% margin of safety to the base estimate.

The Street's Range
12.33Street low 13.09Street average 13.86Street high 6.47Price

Third-party analyst targets: 2 covering, consensus Buy. The average target sits +102% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$14.7$8.8$2.9TODAY5y agoPROJECTIONStreet high$13.86 +105%Street avg$13.09 +93%Conservative$8.73 +29%Our fair value$8.73 +29%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-20 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Gold project burns cash with no profits in sight

Picture a developer sitting on one of North America's largest undeveloped gold deposits yet still posting zero profit margins and a negative 25 percent return on equity. NovaGold Resources shows a forward price to earnings ratio of negative 21.5 times and carries an unknown moat, so the numbers offer no reason to step in. The opportunity rating stays at none and the ethical screen returns insufficient data.

Gold mining sits squarely in a cyclical industry where low or negative multiples often mark peak earnings rather than bargains. Current losses and missing financial detail make any apparent discount look more like a warning than an opening. Analyst targets sit far above the current price but we ignore those calls when the underlying figures fail basic tests.

Currency swings, permitting delays and gold price swings add further layers of risk on top of the data gaps. We pass. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E-32.3x
EPS, trailing-0.21
EPS, forward-0.20
Profit margin0.0%currently unprofitable
Return on equity-32.8%not currently earning a positive return on equity
FCF yield-0.94%
Debt to equity0.46minimal debt: a conservative balance sheet
Current ratio44.51comfortably covers its short-term bills
Beta2.35much more volatile than the market
Short interest, float0.09%
52-week range5.08 - 14.40
Market cap$2.8B
Employees12

The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

NG trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-23 Markdown $6.47 +3.9% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14.

2026-10-16 Markdown $6.23 -15.4% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 15.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14.

2026-10-02 Markdown $7.36 +0.0% Entry 7

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-09-24 Markdown · changed $7.36 -21.0% Entry 6

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 21.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-09-06 Markup · changed $9.32 +79.9% Entry 5

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 79.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14.

2026-08-06 Distribution · changed $5.18 -30.4% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 30.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14.

2026-07-18 Markup $7.44 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 57%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it buy, with a mean price target of $14.

2026-07-03 Markup $7.44 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markup $7.44 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on NG

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in NG's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming NG
DatePoliticianPartyTypeAmount
2026-10-01 Gil Cisneros Democrat exchange 15K–50K
2026-09-30 Lisa McClain Republican sell 15K–50K
2026-09-29 Gil Cisneros Democrat sell 15K–50K
2026-09-29 Gil Cisneros Democrat buy 1K–15K
2026-09-25 Ro Khanna Democrat buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $9.22 -26.6% · $734 -26.6%
2 months $9.48 -28.6% · $714 -28.6%
3 months $11.24 -39.8% · $602 -39.8%
6 months $9.70 -30.2% · $698 -30.2%
1 year $4.32 +56.7% · $1,567 +56.7%
2 years $3.71 +82.5% · $1,825 +82.5%
3 years $5.22 +29.7% · $1,297 +29.7%
5 years $9.72 -30.4% · $697 -30.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever NG does next, these words stay.

NovaGold Resources Inc. · NG · Markdown · $6.47
Recorded 2026-10-20 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.